David Bennett to Enzyme-Linked Immunosorbent Assay
This is a "connection" page, showing publications David Bennett has written about Enzyme-Linked Immunosorbent Assay.
Connection Strength
0.263
-
Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A? and TAU proteostasis. Hum Mol Genet. 2019 03 01; 28(5):718-735.
Score: 0.042
-
Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
Score: 0.036
-
Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
Score: 0.030
-
PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and A?. J Neurosci. 2013 Jun 26; 33(26):10729-40.
Score: 0.029
-
Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol. 2011 Sep; 70(9):788-98.
Score: 0.025
-
ELISA measurement of specific non-antigen-bound antibodies to A?1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects. J Neuroinflammation. 2011 Aug 09; 8:93.
Score: 0.025
-
Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
Score: 0.022
-
Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol. 2009 Jan; 68(1):48-58.
Score: 0.021
-
Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2007 Dec; 12(4):377-90.
Score: 0.019
-
Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2003 Aug; 60(8):1143-8.
Score: 0.014